We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Risk Mitigation Strategies For Nanotechnology

Law360 (October 19, 2007, 12:00 AM EDT) -- Despite regulatory uncertainties and the lack of safety data, companies are rushing nanomaterials to market in a wide variety of FDA regulated product categories. A public inventory of products that claim...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.